Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
478 people get XNPT articles and Market Currents by email alert.
Get email alerts on XNPT »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Business Wire (May 17, 2013)
-
Business Wire (May 3, 2013)
-
Business Wire (Apr 24, 2013)
-
-
Business Wire (Apr 17, 2013)
-
Business Wire (Apr 12, 2013)
-
Business Wire (Apr 5, 2013)
-
Business Wire (Mar 18, 2013)
-
-
Business Wire (Mar 11, 2013)
-
Business Wire (Mar 4, 2013)
-
Business Wire (Mar 4, 2013)
-
Business Wire (Mar 1, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Feb 4, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
Hedge Fund Bridger Management Ups XenoPort StakeMarket Folly • Tue, Jul 20, 2010 -
Steven Cohen's SAC Capital Discloses New XenoPort StakeMarket Folly • Tue, May 25, 2010
-
XenoPort's Solzira a Potential BlockbusterZacks Investment Research • Wed, Jun 17, 2009
-
-
-
Glaxo And Human Genome Have Apparently Seen ReasonStephen Simpson • Mon, Jul 16, 2012
-
-
-
-
-
-
-
-
-
-
-
-
6 Highly Liquid Biotech Stocks With Positive Correlation To VolatilityKapitall • Tue, Jan 31, 2012
-
-
11 Biotech Stocks With Bullish Short TrendsKapitall • Wed, Nov 23, 2011
-
14 Oversold Tech Stocks Undervalued by Target PriceKapitall • Tue, Nov 22, 2011
-
-
20 Oversold Stocks Deeply Undervalued By Target PriceKapitall • Fri, Nov 11, 2011
-
XenoPort's CEO Discusses Q3 2012 Results - Earnings Call TranscriptWed, Oct 24, 2012
-
Xenoport's CEO Discusses Q2 2012 Results - Earnings Call TranscriptTue, Aug 7, 2012
-
XenoPort, Inc. Q2 2009 Earnings Call TranscriptWed, Aug 5, 2009
-
XenoPort, Inc., Q1 2009 Earnings Call Transcript.Tue, May 5, 2009
-
XenoPort Inc. Q4 2008 Earnings Call TranscriptThu, Feb 12, 2009
-
XenoPort, Inc. Q3 2008 Earnings Call TranscriptMon, Nov 24, 2008
-
XenoPort Inc.Q2 2008 Earnings Call TranscriptWed, Aug 6, 2008
-
Xenoport, Inc. Q1 2008 Earnings Call TranscriptTue, May 13, 2008
-
XenoPort Incorporated Q4 2007 Earnings Call TranscriptThu, Feb 14, 2008
-
XenoPort Business Update Call TranscriptTue, Jan 22, 2008
-
Xenoport Q3 2007 Earnings Call TranscriptWed, Nov 7, 2007
-
Business Wire (May 17, 2013)
-
Business Wire (May 3, 2013)
-
Business Wire (Apr 24, 2013)
-
Business Wire (Apr 17, 2013)
-
Business Wire (Apr 12, 2013)
-
Business Wire (Apr 5, 2013)
-
Business Wire (Mar 18, 2013)
-
Business Wire (Mar 11, 2013)
-
Business Wire (Mar 4, 2013)
-
Business Wire (Mar 4, 2013)
-
Business Wire (Mar 1, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Feb 4, 2013)
-
Business Wire (Jan 4, 2013)
-
Business Wire (Dec 7, 2012)
-
Business Wire (Nov 16, 2012)
-
at MarketWatch.com (Nov 8, 2012)
-
Business Wire (Nov 8, 2012)
-
Business Wire (Nov 2, 2012)
XNPT vs. ETF Alternatives
Company Description
Currently, there's no company description for XNPT.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, May 21, 12:26 PM Deutsche Bank isn't ready to give up on XenoPort (XNPT -3.1%) just yet. Despite the disappointing arbaclofen placarbil Phase 3 trial results reported Monday and the subsequent ~22% share price decline, analyst Greg Poole reiterates his Buy rating on the shares albeit with a lower price target of $9 ($12 previous). Comment! [Healthcare, On the Move]
-
Monday, May 20, 12:45 PM
Midday top 10 gainers: AQ +115%. MEAD +104%. RSOL +50%. JASO +46%. CAMT +44%. PACT +32%. HSOL +31%. WBSN +28%. CSUN +27%. PPHM +20%.
Midday top 10 losers: NBG -28%. TISI -17%. IEC -14%. XNPT -12%. VBFC -11%. CHCI -9%. RAVN -9%. SBSA -9%. OSIS -9%. INSY -9%. Comment! [On the Move] -
Monday, May 20, 9:10 AM
Premarket gainers: AQ +116%. MEAD +97%. PACT +38%. WBSN +28%. RSOL +26%. ROSG +16%. JASO +16%. JRCC +14%. QIHU +12%. LDK +9%. PXP +7%. IQNT +5%. VOYA +5%. DANG +5%.
Losers: XNPT -26%. NBG -8%. Comment! [On the Move] - Monday, May 20, 8:04 AM Xenoport (XNPT) plummets 19.26% premarket after saying data from a Phase 3 clinical trial of arbaclofen placarbil did not demonstrate that the treatment provides statistically significant improvement versus a placebo in patients with spasticity due to multiple sclerosis. The company will "terminate further investment in the program." (PR) Comment! [Healthcare, On the Move]
- Wednesday, April 24, 4:27 PM Xenoport (XNPT): Q1 EPS of -$0.50 misses by $0.07. Revenue of $0.5M misses by $0.7M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Friday, April 12, 7:49 AM XenoPort (XNPT) says its restless leg drug Horizant is sold out, and in this case, that's a bad thing. GlaxoSmithKline (GSK), which has commercialization rights to the treatment through the end of this month, reports manufacturing delays have led to a stockout of Horizant. XNPT says it is "evaluating the impact, if any, this will have" on financial expectations. Shares -2.48% premarket. 1 Comment [Healthcare, On the Move]
- Wednesday, March 20, 10:59 AM Wells Fargo's Brian Abrahams is defending XenoPort (XNPT -2.6%) this morning on the back of competitor Biogen's (BIIB +1.5%) positive trial results for its MS treatment Plegridy. He says that, despite the competition, BIIB's multiple sclerosis pill patents should be a positive for XNPT. Most notably, additional patent applications could provide patent protection until 2032 for BIIB's BG-12, which should benefit XNPT's '829 drug, an earlier stage derivative of BG-12, and give it added protection from generic competition. Comment! [Healthcare, On the Move]
-
Tuesday, March 12, 5:48 PM
After-hours top gainers, as of 5:15 p.m.: XNPT +11%. DTSI +8%. ARQL +8%. SGMS +7%. EVER +7%.
After-hours top losers: SPPI -35%. VELT -26%. KTOS -16%. MUX -8%. TEU -8%. 3 Comments [On the Move] - Monday, March 11, 4:09 PM Xenoport (XNPT): Q4 EPS of $0.07 beats by $0.49. Revenue of $0.5M misses by $0.52M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Monday, March 11, 12:10 AM Notable earnings after Monday’s close: CASY, CQB, CVI, DMND, FCEL, HEK, HMIN, PWRD, XNPT Comment! [Earnings]
- Sunday, March 10, 5:35 PM Notable earnings after Monday’s close: CASY, CQB, CVI, DMND, FCEL, HEK, HMIN, PWRD, XNPT Comment! [Earnings]
- Tuesday, February 12, 12:10 AM Notable earnings after Tuesday’s close: ACC, AXLL, BWLD, CLF, CLWR, DDR, FRT, FTI, HTS, LPSN, NRP, NTGR, RAX, RENN, RKUS, SCI, SGEN, SKT, SVM, THRX, TRLA, WU, XNPT 1 Comment [Earnings]
- Monday, February 11, 5:35 PM Notable earnings after Tuesday’s close: ACC, AXLL, BWLD, CLF, CLWR, DDR, FRT, FTI, HTS, LPSN, NRP, NTGR, RAX, RENN, RKUS, SCI, SGEN, SKT, SVM, THRX, TRLA, WU, XNPT 1 Comment [Earnings]
- Wednesday, October 24, 2012, 4:25 PM XenoPort (XNPT): Q3 EPS of -$0.41 beats by $00.02. Revenue of $379K (flat% Y/Y) . (PR) Comment! [Earnings, Healthcare]
- Wednesday, October 24, 2012, 12:10 AM Notable earnings after Wednesday’s close: AB, ACOM, AEM, AKAM, AMP, CCI, CDNS, CLF, CMO, CROX, CTXS, EGHT, ENTR, EQR, FFIV, FIO, IDCC, INFN, KBR, LOGI, LSI, OI, ORLY, RRC, RYL, SGMO, SIMO, SPN, SRCL, SYMC, SYNC, TAL, TER, TEX, TLAB, TQNT, TRN, TSCO, TWI, WLL, WYNN, XNPT, ZNGA Comment! [Earnings]
- Tuesday, October 23, 2012, 5:35 PM Notable earnings after Wednesday’s close: AB, ACOM, AEM, AKAM, AMP, CCI, CDNS, CLF, CMO, CROX, CTXS, EGHT, ENTR, EQR, FFIV, FIO, IDCC, INFN, KBR, LOGI, LSI, OI, ORLY, RRC, RYL, SGMO, SIMO, SPN, SRCL, SYMC, SYNC, TAL, TER, TEX, TLAB, TQNT, TRN, TSCO, TWI, WLL, WYNN, XNPT, ZNGA Comment! [Earnings]